13F Filings History of BB BIOTECH AG

Latest 13F report
Q4 2025 - 17 Feb 2026
Signature - Title
Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen
Summary
This page shows a list of all the recent 13F filings made by BB BIOTECH AG. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BB BIOTECH AG reported 35 stock holdings with total value $3,977,857,000 as of Q1 2019. Top holdings included IONS, INCY, NBIX, VRTX, and SAGE. Bellevue Group AG is reporting for BB BIOTECH AG.

Notify me when BB BIOTECH AG files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value

Bellevue Group AG is reporting for BB BIOTECH AG:

Name Holdings Value Location File Number
Bellevue Group AG $5,276,933,294 Zurich 028-17462
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 $0 13F-NT 17 Feb 2026, 16:00
Q3 2025 $0 13F-NT 14 Nov 2025, 17:08
Q2 2025 $0 13F-NT 14 Aug 2025, 15:23
Q1 2025 $0 13F-NT 14 May 2025, 16:46
Q4 2024 $0 13F-NT 14 Feb 2025, 16:18
Q3 2024 $0 13F-NT 14 Nov 2024, 17:23
Q2 2024 $0 13F-NT 14 Aug 2024, 14:11
Q1 2024 $0 13F-NT 15 May 2024, 15:07
Q4 2023 $0 13F-NT 14 Feb 2024, 12:17
Q3 2023 0 $0 13F-NT 14 Nov 2023, 13:59
Q2 2023 0 $0 13F-NT 14 Aug 2023, 12:58
Q1 2023 0 $0 13F-NT 15 May 2023, 10:31
Q4 2022 0 $0 13F-NT 14 Feb 2023, 11:51
Q3 2022 0 $0 13F-NT 14 Nov 2022, 13:01
Q2 2022 0 $0 13F-NT 11 Aug 2022, 11:01
Q1 2022 0 $0 13F-NT 13 May 2022, 16:24
Q4 2021 0 $0 13F-NT 10 Feb 2022, 09:57
Q3 2021 0 $0 13F-NT 12 Nov 2021, 05:35
Q2 2021 0 $0 13F-NT 12 Aug 2021, 12:54
Q1 2021 0 $0 13F-NT 11 May 2021, 17:49
Q4 2020 0 $0 13F-NT 16 Feb 2021, 08:10
Q3 2020 0 $0 13F-NT 16 Nov 2020, 15:25
Q2 2020 0 $0 13F-NT 13 Aug 2020, 16:07
Q1 2020 0 $0 13F-NT 14 May 2020, 14:26
Q4 2019 0 $0 13F-NT 14 Feb 2020, 13:33
Q3 2019 0 $0 13F-NT 14 Nov 2019, 15:58
Q2 2019 0 $0 13F-NT 14 Aug 2019, 14:29
Q1 2019 35 $3,977,857,000 +$158,997,958 -$159,509,478 -$511,520 IONS, INCY, NBIX, VRTX, SAGE 13F-HR 13 May 2019, 12:49
Q4 2018 34 $3,121,404,000 +$321,655,985 -$250,859,878 +$70,796,107 IONS, INCY, NBIX, VRTX, ESPR 13F-HR 12 Feb 2019, 17:21
Q3 2018 32 $3,778,941,000 +$163,552,007 -$139,592,561 +$23,959,446 IONS, NBIX, CELG, VRTX, INCY 13F-HR 09 Nov 2018, 16:57
Q2 2018 32 $3,463,411,000 +$224,847,014 -$149,474,743 +$75,372,271 IONS, NBIX, CELG, INCY, VRTX 13F-HR 09 Aug 2018, 16:17
Q1 2018 30 $3,618,344,000 +$168,928,180 -$134,913,753 +$34,014,427 IONS, INCY, CELG, NBIX, VRTX 13F-HR 08 May 2018, 17:23
Q4 2017 30 $3,551,094,000 +$158,720,498 -$26,437,597 +$132,282,901 IONS, CELG, INCY, NBIX, VRTX 13F-HR 14 Feb 2018, 15:39
Q3 2017 27 $3,612,448,000 +$159,333,991 -$102,561,576 +$56,772,415 CELG, INCY, IONS, GILD, VRTX 13F-HR 13 Nov 2017, 11:56
Q2 2017 28 $3,271,610,000 +$90,394,483 -$82,061,386 +$8,333,097 INCY, CELG, IONS, RDUS, GILD 13F-HR 11 Aug 2017, 13:46
Q1 2017 30 $3,057,070,000 +$92,046,591 -$99,926,915 -$7,880,324 INCY, CELG, IONS, GILD, RDUS 13F-HR 10 May 2017, 12:34
Q4 2016 29 $2,700,058,000 +$80,602,106 -$66,826,814 +$13,775,292 CELG, INCY, IONS, GILD, RDUS 13F-HR 14 Feb 2017, 14:10
Q3 2016 29 $2,844,785,000 +$107,323,235 -$172,403,774 -$65,080,539 INCY, CELG, IONS, RDUS, GILD 13F-HR 10 Nov 2016, 16:17
Q2 2016 30 $2,533,389,000 +$89,290,114 -$66,254,759 +$23,035,355 CELG, INCY, GILD, IONS, RDUS 13F-HR 12 Aug 2016, 16:55
Q1 2016 29 $2,516,156,000 +$37,797,138 -$4,445,805 +$33,351,333 CELG, INCY, IONS, GILD, ALXN 13F-HR 12 May 2016, 17:12
Q4 2015 30 $3,549,967,000 +$474,848,040 -$292,407,087 +$182,440,953 CELG, INCY, IONS, GILD, RDUS 13F-HR 09 Feb 2016, 17:02
Q3 2015 28 $3,153,768,000 +$322,749,203 -$139,280,006 +$183,469,197 INCY, CELG, RDUS, GILD, ISIS 13F-HR 12 Nov 2015, 08:48
Q2 2015 29 $3,688,933,000 +$229,746,663 -$168,224,910 +$61,521,753 CELG, INCY, ISIS, GILD, RDUS 13F-HR 12 Aug 2015, 12:03
Q1 2015 27 $3,356,981,000 +$138,105,397 -$201,860,753 -$63,755,356 CELG, ISIS, INCY, GILD, AGIO 13F-HR 14 May 2015, 15:12
Q4 2014 28 $3,087,629,000 +$175,873,054 -$120,673,788 +$55,199,266 CELG, ISIS, INCY, GILD, AGIO 13F-HR 12 Feb 2015, 17:27
Q3 2014 26 $2,459,442,000 +$205,167,266 -$163,208,193 +$41,959,073 CELG, GILD, ISIS, INCY, VRTX 13F-HR 13 Nov 2014, 16:53
Q2 2014 24 $2,104,545,000 +$316,773,763 -$15,339,944 +$301,433,819 CELG, GILD, INCY, ISIS, VRTX 13F-HR 07 Aug 2014, 15:43
Q1 2014 24 $1,939,867,000 +$71,234,889 -$32,938,152 +$38,296,737 CELG, ISIS, GILD, INCY, ALXN 13F-HR 08 May 2014, 16:51
Q4 2013 23 $1,871,689,000 $0 $0 $0 CELG, GILD, ISIS, INCY, VRTX 13F-HR 12 Feb 2014, 12:36